Low Molecular Weight Heparin (CY 216) Does Not Cross the Placenta During the Third Trimester of Pregnancy

Thromb Haemost 1987; 57(02): 234
DOI: 10.1055/s-0038-1651102

Letters to the Editor

Schattauer GmbH Stuttgart

François Forestier

¹Centre de Diagnostic Prénatal et de Foetologie, Hôpital ND. de Bon-Secours, 75014 Paris

,

Fernand Daffos

¹Centre de Diagnostic Prénatal et de Foetologie, Hôpital ND. de Bon-Secours, 75014 Paris

,

Martine Rainaut

¹Centre de Diagnostic Prénatal et de Foetologie, Hôpital ND. de Bon-Secours, 75014 Paris

,

Francis Toulemonde

¹Service des Recherches Thérapeutiques, Institut CHOAY, 46 Av. Théophile Gautier, 75016 Paris, France

References
1 Letsky EA, Swiet MD. Thromboembolism in pregnancy and its management. Br J Haematol 1984; 57: 543-552
2 Aiach M, Michael A, Balian JL, Lefevre M, Woler M, Fourtillon J. A new low molecular weight heparin derivative. In vitro and in vivo studies. Thromb Res 1983; 31: 611-621
3 Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound. A study of 606 consecutive cases. Am J Obstet Gynecol 1985; 153: 655-660
4 Andrew M, Ofosu F, Fernandez F, Jefferies A, Hirsh J, Mitchell L, Buchanan MR. A low molecular weight heparin alters the fetal coagulation system in the pregnant sheep. Thromb Haemostas 1986; 55: 342-346
5 Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: Study by direct fetal blood sampling under ultrasound. Thromb Res 1984; 34: 557
6 Henny ChP, Ten Cate H, Ten Cate JW, Prummel MF, Peters M, Buller HR. Thrombosis prophylaxis in an AT III deficient pregnant women: application of a low molecular weight heparinoid. Thromb Haemostas 1986; 55: 301